This inventor holds 4 USPTO granted patents. Top assignees: University of Miami, Viragen Incorporated. Active years: 1997-2002.
Company Filing History:
Years Active: 1997-2002
Title: Mead M McCabe: Innovator in Interferon Research
Introduction
Mead M McCabe is a notable inventor based in Miami, FL, who has made significant contributions to the field of medical research, particularly in the area of interferon. With a total of four patents to his name, McCabe's work focuses on isolating and purifying natural mixtures of Type I interferon derived from leukocytes.
Latest Patents
McCabe's latest patents revolve around the compositions of highly-purified natural mixtures of Type I interferon. These inventions detail methods for isolating these interferons from white blood cells, emphasizing the importance of obtaining highly purified mixtures that include at least nine subtypes. The subtypes identified in his patents include alpha-1, alpha-2, alpha-5, alpha-7, alpha-8, alpha-10, alpha-14, alpha-21, and omega. This research has the potential to yield at least 16, and possibly 20 or more molecular species, which could have significant implications for medical treatments.
Career Highlights
Throughout his career, Mead M McCabe has worked with various organizations, including Viragen Incorporated and the University of Miami. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of McCabe's notable coworkers include Joseph P Morris and Duy Nguyen, who have collaborated with him on various projects related to his research in interferon.
Conclusion
Mead M McCabe's innovative work in the field of interferon research highlights his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through scientific discovery.